MarkGordenMartensMD
Obstetrics & Gynecology • Reading, PAMaternal & Fetal Medicine/High Risk, STD Gynecology
Chairman
Dr. Martens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 S 5th Ave
Reading, PA 19611Phone+1 484-628-8333Fax+1 484-628-8334
Education & Training
University of ConnecticutResidency, Obstetrics and Gynecology, 1982 - 1986
George Washington University School of Medicine and Health SciencesClass of 1982
Certifications & Licensure
MN State Medical License 1995 - 2025
NJ State Medical License 2009 - 2025
NY State Medical License 2023 - 2024
PA State Medical License 2018 - 2024
OK State Medical License 2002 - 2018
AR State Medical License 2009 - 2011
TX State Medical License 1987 - 2005- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- Join now to see all
Awards, Honors, & Recognition
- Inside Jersey Magazine Top Doctors Castle Connolly, 2012-2014
- Top Doctors: New York Metro Area Castle Connolly, 2012-2014
- Inside Jersey - Top Doctors for Women's Health Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies Start of enrollment: 2012 Mar 01
- Pivotal Study of the Rx Al-Sense Liner for Amniotic Fluid Leakage Screening Start of enrollment: 2016 Nov 01
Publications & Presentations
PubMed
- 22 citationsPhase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.Mark G Martens, Bassem Maximos, Thorsten Degenhardt, Karen Person, Stacey Curelop
American Journal of Obstetrics and Gynecology. 2022-12-01 - 11 citationsTopical Treatment of Recurrent Vulvovaginal Candidiasis: An Expert Consensus.Nancy A Phillips, Gloria Bachmann, Hope Haefner, Mark Martens, Colleen Stockdale
Women's Health Reports. 2022-01-01 - 38 citationsSafety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial.Guy de Bruyn, David L. Gordon, Theodore Steiner, Paul A. Tambyah, Catherine Cosgrove
The Lancet. Infectious Diseases. 2021-02-01
Press Mentions
Tower Health and College of Medicine Break Ground on New Four-Year Regional CampusJune 18th, 2019
Monsanto on Trial: Monsanto's Key Witness on the Animal Studies Admitted His Earlier Calculations Were All Wildly WrongAugust 9th, 2018
New Way to More Accurately Detect Cervical Cancer in WomenAugust 7th, 2014- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
